Page last updated: 2024-08-22

titanium and notoginsenoside r1

titanium has been researched along with notoginsenoside r1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, X; Sun, Y; Wang, J; Yan, L; Zhang, Z; Zhao, S1

Other Studies

1 other study(ies) available for titanium and notoginsenoside r1

ArticleYear
Notoginsenoside R1 suppresses wear particle-induced osteolysis and RANKL mediated osteoclastogenesis in vivo and in vitro.
    International immunopharmacology, 2017, Volume: 47

    Topics: Animals; Arthroplasty, Replacement; Bone Resorption; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Ginsenosides; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteolysis; Postoperative Complications; Prosthesis Failure; RANK Ligand; RAW 264.7 Cells; Signal Transduction; Titanium

2017